PUBLISHER: Inkwood Research | PRODUCT CODE: 1245404
PUBLISHER: Inkwood Research | PRODUCT CODE: 1245404
The India cellulite treatment market is forecasted to progress with a CAGR of 10.25% during the estimated period. Some of the key drivers augmenting the market growth of the country include the increasing prevalence of obesity, the presence of a significant number of qualified professionals, and the surging number of cosmetic procedures performed in India. While the base year regarded for the studied market is 2022, the forecast years are from 2023 to 2030.
Cellulite entails the collection of fat pushing against the connective tissue under the skin. It appears on the thighs, stomach, and buttocks. Cellulite affects women more than men owing to the different fat, muscle, as well as connective tissue distribution. Accordingly, cellulite treatment refers to the process of the removal of subcutaneous fat through different procedures.
According to the data issued by the Global Obesity Observatory, obesity prevalence in India was approximately 23.4% between 2019 to 2021. The high obesity rate, coupled with the increase in the elderly population, is expected to bolster the demand for cellulite treatment products over the upcoming years. Moreover, the high consciousness regarding physical appearances as well as exposure to various social media applications and beauty standards, are expected to further boost the demand for these treatments. As a result, the aforementioned factors are set to propel the cellulite treatment market growth in India during the forecast period.
Some of the main players operating in the market include: Zimmer MedizinSysteme, Nubway Co Ltd, Merz Pharma GmbH & Co KGaA, etc.